Ametek Inc. (AME) engages in the manufacture of electronic instruments and electromechanical devices. Top research laboratories are using their solutions to assist in the development of vaccines and antibodies, so the company is critical to vaccine corona vaccine efforts. AME has been deemed an…
essential or life-sustaining business.
The company also can withstand an economic downturn with $1.8 billion in liquidity and $1.25 billion cash on hand. AMA owns a significant market share in its industry as it can produce and deliver high-quality products at competitive prices. As of the end of 2019, its revenues grew at an annual growth rate 5.1%. EPS grew at a rate of 11.6%. AME delivered sound first-quarter results, which was highlighted by excellent operating performance.
The firm’s strategy emphasizes growth through acquisitions and new product development. The company is well-positioned to improve China’s growth by the end of the year as its products support in-demand thermal nuclear power plants and environmental cleanup.
Management has an excellent track record of executing its strategy of acquisition-driven growth, sound operational execution, and free cash flow generation. AME should continue to benefit from its acquisition strategy and growth investments.
The Tale of the Tape
Take a look at the 1-year chart of Ametek below with the added notations…
See chart and continue reading at STOCKNEWS.com